Earnings consistently backed by cash
Operating cash flow has matched or exceeded reported profit in 5 of the last 6 profit-making years (latest 1.38×).
Importance 49 / 95 · cash quality
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Operating cash flow has matched or exceeded reported profit in 5 of the last 6 profit-making years (latest 1.38×).
Importance 49 / 95 · cash quality
Free cash flow has been positive in 5 of the last 5 years.
Importance 44 / 95 · cash quality
Revenue has compounded at 6.4% a year over 7 years (₹8,533 → ₹13,193) — steady rather than rapid.
Importance 28 / 95 · growth
Classified by the exchange under Fast Moving Consumer Goods › Fast Moving Consumer Goods › Personal Products › Personal Care.
Peer set used on this page: 3 personal care.
Revenue has compounded at 6.4% a year over 7 years (₹8,533 → ₹13,193) — steady rather than rapid.
Rule REVENUE_COMPOUNDED_MODERATE
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q1 FY27 net profit was ₹586 cr, up 15.3% from ₹508 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q1 FY27 revenue was ₹3,764 cr, up 10.6% from ₹3,405 cr in Q1 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q1 FY27 net profit of ₹586 cr is the highest of the 16 quarters on record for this company.
Rule QTR_PROFIT_AT_RECORD
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q2 FY25 | 3,029 | — | 418 | — | 13.8% |
| Q3 FY25 | 3,355 | +3.1% | 516 | +1.9% | 15.4% |
| Q4 FY25 | 2,830 | +0.6% | 313 | −8.3% | 11.0% |
| Q1 FY26 | 3,405 | +1.7% | 508 | +2.8% | 14.9% |
| Q2 FY26 | 3,191 | +5.4% | 445 | +6.5% | 13.9% |
| Q3 FY26 | 3,559 | +6.1% | 554 | +7.3% | 15.6% |
| Q4 FY26 | 3,038 | +7.3% | 362 | +15.8% | 11.9% |
| Q1 FY27 | 3,764 | +10.6% | 586 | +15.3% | 15.6% |
Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters
Margin and return trends are shown above.
Operating cash flow has matched or exceeded reported profit in 5 of the last 6 profit-making years (latest 1.38×).
Rule CFO_CONSISTENTLY_EXCEEDS_PAT
Free cash flow has been positive in 5 of the last 5 years.
Ranked against 3 personal care (FY2026, consolidated). No peer-relative rule fired for this company.
DABUR · 2nd of 3 · set median 5.0%
DABUR · 2nd of 3 · set median 23.1%
DABUR · 2nd of 3 · set median 16.2%
DABUR · 1st of 3 · set median 35.0×
On the trailing twelve months. Last full year: P/E 35.8× · P/S 4.8× · ROE 16.2%.
Long-term price performance is shown above.
Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6,273 | 6,310 | 7,185 | 8,180 | 8,684 | 9,136 | 9,071 | 9,383 |
| Total income | 6,548 | 6,587 | 7,461 | 8,521 | 9,077 | 9,553 | 9,523 | 9,861 |
| EBITDA | 1,642 | 1,658 | 1,836 | 2,075 | 2,093 | 2,257 | 2,159 | 2,259 |
| Profit before tax | 1,503 | 1,408 | 1,683 | 1,896 | 1,829 | 1,967 | 1,808 | 1,901 |
| Net profit | 1,264 | 1,170 | 1,382 | 1,433 | 1,373 | 1,509 | 1,403 | 1,491 |
| EPS (₹) | 7.2 | 6.6 | 7.8 | 8.1 | 7.8 | 8.5 | 7.9 | 8.4 |
| Net worth | 3,969 | 4,574 | 5,391 | 5,864 | 6,287 | 6,915 | 7,423 | 7,527 |
| Total debt | 135 | 114 | 172 | 551 | 557 | 698 | 285 | 516 |
| Operating cash flow | — | — | 1,683 | 1,320 | 1,562 | 1,653 | 1,623 | 1,885 |
| Free cash flow | — | — | — | 1,025 | 1,173 | 1,198 | 1,273 | 1,648 |
| Ratio | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||
| Revenue growth YoY | — | 0.6 | 13.9 | 13.8 | 6.2 | 5.2 | -0.7 | 3.4 |
| Profit growth YoY | — | -7.4 | 18.1 | 3.7 | -4.2 | 9.9 | -7.0 | 6.3 |
| Profitability | ||||||||
| EBITDA margin % | 26.2 | 26.3 | 25.6 | 25.4 | 24.1 | 24.7 | 23.8 | 24.1 |
| Net margin % | 19.3 | 17.8 | 18.5 | 16.8 | 15.1 | 15.8 | 14.7 | 15.1 |
| Return on equity % | 31.9 | 27.4 | 27.7 | 25.5 | 22.6 | 22.9 | 19.6 | 19.9 |
| Return on capital % | 37.4 | 34.8 | 33.0 | 32.0 | 28.7 | 28.3 | 24.9 | 25.4 |
| Leverage & cash | ||||||||
| Debt to equity | 0.03 | 0.02 | 0.03 | 0.09 | 0.09 | 0.10 | 0.04 | 0.07 |
| Cash flow ÷ profit | — | — | 1.22 | 0.92 | 1.14 | 1.10 | 1.16 | 1.26 |
| Current ratio | 1.40 | 2.26 | 1.39 | 1.14 | 0.85 | 1.19 | 1.28 | 1.56 |